These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 9131407)

  • 1. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors.
    Nicholas RA; Lazarowski ER; Watt WC; Li Q; Boyer J; Harden TK
    J Auton Pharmacol; 1996 Dec; 16(6):319-23. PubMed ID: 9131407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.
    Nicholas RA; Watt WC; Lazarowski ER; Li Q; Harden K
    Mol Pharmacol; 1996 Aug; 50(2):224-9. PubMed ID: 8700127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
    Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.
    Schachter JB; Li Q; Boyer JL; Nicholas RA; Harden TK
    Br J Pharmacol; 1996 May; 118(1):167-73. PubMed ID: 8733591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells.
    Sabala P; Czajkowski R; Przybyłek K; Kalita K; Kaczmarek L; Barańska J
    Br J Pharmacol; 2001 Jan; 132(2):393-402. PubMed ID: 11159687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of competitive antagonists of the P2Y1 receptor.
    Boyer JL; Romero-Avila T; Schachter JB; Harden TK
    Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecularly identified P2Y receptor simultaneously activates phospholipase C and inhibits adenylyl cyclase and is nonselectively activated by all nucleoside triphosphates.
    Boyer JL; Delaney SM; Villanueva D; Harden TK
    Mol Pharmacol; 2000 Apr; 57(4):805-10. PubMed ID: 10727529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pharmacology of P2Y-receptors.
    von Kügelgen I; Wetter A
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):310-23. PubMed ID: 11111826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C.
    Schachter JB; Boyer JL; Li Q; Nicholas RA; Harden TK
    Br J Pharmacol; 1997 Nov; 122(6):1021-4. PubMed ID: 9401764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a uridine nucleotide-selective G-protein-linked receptor that activates phospholipase C.
    Lazarowski ER; Harden TK
    J Biol Chem; 1994 Apr; 269(16):11830-6. PubMed ID: 8163481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor.
    Jin J; Tomlinson W; Kirk IP; Kim YB; Humphries RG; Kunapuli SP
    Br J Pharmacol; 2001 Jun; 133(4):521-8. PubMed ID: 11399669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
    Filtz TM; Li Q; Boyer JL; Nicholas RA; Harden TK
    Mol Pharmacol; 1994 Jul; 46(1):8-14. PubMed ID: 8058061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase.
    Boyer JL; Lazarowski ER; Chen XH; Harden TK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1140-6. PubMed ID: 8263774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An examination of deoxyadenosine 5'(alpha-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptor.
    Schachter JB; Harden TK
    Br J Pharmacol; 1997 May; 121(2):338-44. PubMed ID: 9154346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterisation of pyrimidinoceptor responses in NG108-15 cells.
    Sak K; Samuel K; Kelve M; Webb TE
    Eur J Pharmacol; 2001 Mar; 415(2-3):127-33. PubMed ID: 11274990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
    von Kügelgen I
    Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.
    El-Tayeb A; Qi A; Müller CE
    J Med Chem; 2006 Nov; 49(24):7076-87. PubMed ID: 17125260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that P2Y4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP.
    Harper S; Webb TE; Charlton SJ; Ng LL; Boarder MR
    Br J Pharmacol; 1998 Jun; 124(4):703-10. PubMed ID: 9690862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of brain capillary endothelial cells by P2Y receptors coupled to Ca2+, phospholipase C and mitogen-activated protein kinase.
    Albert JL; Boyle JP; Roberts JA; Challiss RA; Gubby SE; Boarder MR
    Br J Pharmacol; 1997 Nov; 122(5):935-41. PubMed ID: 9384512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADP-evoked phospholipase C stimulation and adenylyl cyclase inhibition in glioma C6 cells occur through two distinct nucleotide receptors, P2Y(1) and P2Y(12).
    Czajkowski R; Lei L; Sabała P; Barańska J
    FEBS Lett; 2002 Feb; 513(2-3):179-83. PubMed ID: 11904146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.